Literature DB >> 18523774

Radiologist experience and CT examination quality determine metastasis detection in patients with esophageal or gastric cardia cancer.

E P M van Vliet1, J J Hermans, W De Wever, M J C Eijkemans, E W Steyerberg, C Faasse, E P M van Helmond, A M de Leeuw, A C Sikkenk, A R de Vries, E H de Vries, E J Kuipers, P D Siersema.   

Abstract

We aimed to separate the influence of radiologist experience from that of CT quality in the evaluation of CT examinations of patients with esophageal or gastric cardia cancer. Two radiologists from referral centers ('expert radiologists') and six radiologists from regional non-referral centers ('non-expert radiologists') performed 240 evaluations of 72 CT examinations of patients diagnosed with esophageal or gastric cardia cancer between 1994 and 2003. We used conditional logistic regression analysis to calculate odds ratios (OR) for the likelihood of a correct diagnosis. Expert radiologists made a correct diagnosis of the presence or absence of distant metastases according to the gold standard almost three times more frequently (OR 2.9; 95% CI 1.4-6.3) than non-expert radiologists. For the subgroup of CT examinations showing distant metastases, a statistically significant correlation (OR 3.5; 95% CI 1.4-9.1) was found between CT quality as judged by the radiologists and a correct diagnosis. Both radiologist experience and quality of the CT examination play a role in the detection of distant metastases in esophageal or gastric cardia cancer patients. Therefore, we suggest that staging procedures for esophageal and gastric cardia cancer should preferably be performed in centers with technically advanced equipment and experienced radiologists.

Entities:  

Mesh:

Year:  2008        PMID: 18523774     DOI: 10.1007/s00330-008-1052-4

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  32 in total

1.  Evaluation of the accuracy of preoperative staging in thoracic esophageal cancer.

Authors:  T Nishimaki; O Tanaka; N Ando; H Ide; H Watanabe; M Shinoda; W Takiyama; H Yamana; K Ishida; K Isono; M Endo; T Ikeuchi; T Mitomi; H Koizumi; M Imamura; T Iizuka
Journal:  Ann Thorac Surg       Date:  1999-12       Impact factor: 4.330

2.  Improved detection of individual nodal involvement in squamous cell carcinoma of the esophagus by FDG PET.

Authors:  J Y Choi; K H Lee; Y M Shim; K S Lee; J J Kim; S E Kim; B T Kim
Journal:  J Nucl Med       Date:  2000-05       Impact factor: 10.057

3.  Comparison of positron emission tomography, computed tomography, and endoscopic ultrasound in the initial staging of patients with esophageal cancer.

Authors:  Val J Lowe; Fargol Booya; J G Fletcher; Mark Nathan; Eric Jensen; Brian Mullan; Eric Rohren; Maurits J Wiersema; Enrique Vazquez-Sequeiros; Joseph A Murray; Mark S Allen; Michael J Levy; Jonathan E Clain
Journal:  Mol Imaging Biol       Date:  2005 Nov-Dec       Impact factor: 3.488

4.  Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma.

Authors:  P Flamen; A Lerut; E Van Cutsem; W De Wever; M Peeters; S Stroobants; P Dupont; G Bormans; M Hiele; P De Leyn; D Van Raemdonck; W Coosemans; N Ectors; K Haustermans; L Mortelmans
Journal:  J Clin Oncol       Date:  2000-09-15       Impact factor: 44.544

5.  A comparison between low-volume referring regional centers and a high-volume referral center in quality of preoperative metastasis detection in esophageal carcinoma.

Authors:  Evelyn P M van Vliet; Marinus J C Eijkemans; Ernst J Kuipers; John J Hermans; Ewout W Steyerberg; Hugo W Tilanus; Ate van der Gaast; Peter D Siersema
Journal:  Am J Gastroenterol       Date:  2006-02       Impact factor: 10.864

6.  Superficial esophageal carcinoma: evaluation by endoscopic ultrasonography.

Authors:  H Yoshikane; Y Tsukamoto; Y Niwa; H Goto; S Hase; M Shimodaira; S Maruta; A Miyata; M Yoshida
Journal:  Am J Gastroenterol       Date:  1994-05       Impact factor: 10.864

7.  Positron emission tomography for staging esophageal cancer: does it lead to a different therapeutic approach?

Authors:  Werner Kneist; Mathias Schreckenberger; Peter Bartenstein; Frank Grünwald; Katja Oberholzer; Theodor Junginger
Journal:  World J Surg       Date:  2003-08-18       Impact factor: 3.352

8.  Computed tomography in staging of oesophageal carcinoma.

Authors:  O Salonen; L Kivisaari; C G Standertskjöld-Nordenstam; K Somer; P Virkkunen
Journal:  Scand J Gastroenterol       Date:  1987-01       Impact factor: 2.423

9.  Computed tomography or endoscopic ultrasonography in preoperative staging of gastric and esophageal tumors.

Authors:  J Greenberg; M Durkin; M Van Drunen; G V Aranha
Journal:  Surgery       Date:  1994-10       Impact factor: 3.982

10.  The questionable role of computed tomography in preoperative staging of esophageal cancer.

Authors:  J W Lea; R L Prager; H W Bender
Journal:  Ann Thorac Surg       Date:  1984-11       Impact factor: 4.330

View more
  4 in total

1.  Diagnostic accuracy of magnetic resonance imaging and magnetic resonance arthrography of the hip is dependent on specialist training of the radiologist.

Authors:  Ciara M McGuire; Peter MacMahon; Damien P Byrne; Eoin Kavanagh; Kevin J Mulhall
Journal:  Skeletal Radiol       Date:  2011-09-14       Impact factor: 2.199

2.  Magnetic resonance imaging and magnetic resonance arthrography of the shoulder: dependence on the level of training of the performing radiologist for diagnostic accuracy.

Authors:  John S Theodoropoulos; Gustav Andreisek; Edward J Harvey; Preston Wolin
Journal:  Skeletal Radiol       Date:  2009-10-14       Impact factor: 2.199

3.  Clinical variation in the organization of clinical pathways in esophagogastric cancer, a mixed method multiple case study.

Authors:  P A J Vissers; R H A Verhoeven; G A P Nieuwenhuijzen; M J Westerman; J C H B M Luijten; L Brom; M de Bièvre; J Buijsen; T Rozema; N Haj Mohammad; P van Duijvendijk; E A Kouwenhoven; W J Eshuis; C Rosman; P D Siersema; H W M van Laarhoven
Journal:  BMC Health Serv Res       Date:  2022-04-20       Impact factor: 2.908

4.  A clinical metabolomics-based biomarker signature as an approach for early diagnosis of gastric cardia adenocarcinoma.

Authors:  Yuanfang Sun; Shasha Li; Jin Li; Xue Xiao; Zhaolai Hua; Xi Wang; Shikai Yan
Journal:  Oncol Lett       Date:  2019-12-02       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.